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Abstract
Background
Patient outcomes in gastric adenocarcinoma are poor due to late diagnosis. Detecting and treating 
at the premalignant stage has the potential to improve this. H. pylori is also a strong risk factor 
for this disease. 
Aims
Primary aims were to assess the diagnostic accuracy of magnified narrow band imaging (NBI-Z) 
endoscopy and serology in detecting normal mucosa, H. pylori gastritis and gastric atrophy. 
Secondary aims were to compare the diagnostic accuracies of two classification systems using 
both NBI-Z and white light endoscopy with magnification (WLE-Z) and evaluate the inter-
observer agreement.
Methods
Patients were prospectively recruited. Images of gastric mucosa were stored with histology and 
serum for IgG H. pylori and Pepsinogen (PG) I/II ELISAs. Blinded expert endoscopists agreed 
on mucosal pattern. Mucosal images and serological markers were compared with histology. 
Kappa statistics determined inter-observer variability for randomly allocated images among four 
experts and four non-experts. 
Results
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116 patients were prospectively recruited. Diagnostic accuracy of NBI-Z for determining normal 
gastric mucosa was 0.87(95%CI 0.82-0.92), H. pylori gastritis 0.65(95%CI 0.55-0.75) and 
gastric atrophy 0.88(95%CI 0.81-0.94). NBI-Z was superior to serology at detecting gastric 
atrophy: NBI-Z gastric atrophy 0.88(95%CI 0.81-0.94) vs PGI/II ratio<3 0.74(95%CI 0.62-0.85) 
p<0.0001. Overall NBI-Z was superior to WLE-Z in detecting disease using two validated 
classifications. Inter-observer agreement was 0.63(95%CI 0.51-0.73).
Conclusions
NBI-Z accurately detects changes in the GI mucosa which currently depend on histology. NBI-Z 
is useful in the detection of precancerous lesions, potentially improving patient outcomes with 
early intervention to prevent gastric cancer.  
Introduction
Helicobacter pylori (H. pylori) colonizes the gastric mucosa of approximately 50% of the 
world’s population, although the prevalence varies between countries the infection rates are 
higher in developing countries (1, 2). H. pylori infects individuals during childhood and typically 
persists lifelong in the absence of effective eradication therapy (3). In 15% of individuals 
infection leads to serious complications such as peptic ulcer disease, distal gastric 
adenocarcinoma or primary gastric mucosa associated lymphoid tissue (MALT) lymphoma (4). 
Other conditions associated with H. pylori include iron deficiency anemia, gastric atrophy and 
idiopathic thrombocytopenia purpura (5, 6). H. pylori infection has also been suggested to be a 
significant contributor to the hygiene hypothesis and the development of a healthy immune 
system (4, 7).
Gastric atrophy occurs as a result of a chronic gastric mucosal inflammation, usually due to H. 
pylori infection, leading to loss of specialized glandular cells and replacement with an intestinal 
type surface and fibrous tissue (8). This may then progress to intestinal metaplasia then dysplasia 
and finally intestinal type gastric cancer. The development from normal mucosa to gastric cancer 
is gradual and in a stepwise manner (9). The annual incidence of progression from intestinal 
metaplasia to gastric cancer varies from 0.1% to 0.9% (10). The annual incidence increases to 
6% in dysplasia (11, 12). Gastric atrophy is, therefore, considered a pre-cancerous condition and 
current European guidelines recommend endoscopic surveillance of these high risk patients with 
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severe atrophy (13). Unfortunately, at present these premalignant mucosal changes are often 
disregarded in routine clinical practice or result in variable surveillance frequency (14). Gastric 
cancer is ranked the fifth most common malignancy worldwide (15) and is the third most 
common cause of cancer related death (16). In order to reduce this associated mortality, one 
possibility is to detect premalignant disease using advanced endoscopy techniques. However, 
due to variety in endoscopic techniques and mucosal classifications the diagnosis is often 
dependent on histology. 
High definition magnified white light endoscopy (WLE-Z) allows for detailed assessment of 
mucosal pit and vascular pattern, magnifying images by factors greater than 100 with resolutions 
smaller than 7.9µm (17-19). Narrow band imaging (NBI) relies on specific wavelengths of light 
to produce a sharper contrast between mucosal and vascular structures enhancing detail (20, 21). 
NBI endoscopes enable the endoscopist to easily switch from WLE to NBI to optimize 
visualization and sampling.  
Standard WLE mucosal appearances often correlate poorly with histology and there is no widely 
accepted consensus on the macroscopic appearance, therefore, clinicians are reliant on histology 
which is dependent on multiple factors such as biopsy area, biopsy numbers and experience of 
the histopathologist (22, 23). Anagnostopoulos et al proposed a classification using WLE-Z 
which was highly accurate for detecting normal, H. pylori gastritis and gastric atrophy with 
sensitivity and specificity of 90-100%. Using this classification a normal gastric corpus 
microvasculature consists of a honeycomb type sub epithelial capillary network (SECN) with a 
regular arrangement of collecting venules and round pits. In the inflamed corpus, the normal 
SECN pattern and collecting venules are lost with enlarged white pits surrounded by erythema. 
Gastric atrophy is characterized by loss of the normal SECN and round pits, with an irregular 
distribution of collecting venules (18). Pimentel et al described a more detailed NBI 
classification that also included intestinal metaplasia and dysplasia with accuracy of 84% and 
95% respectively (24). The light blue crest (blue-whitish patchy reflections sited on the epithelial 
margins) appearance in magnified NBI (NBI-Z)  of gastric mucosa was first described by Uedo 
et al and correlated well to intestinal metaplasia with an accuracy of 91% (25). White Opaque 
Substance (WOS) is also sometimes associated with epithelial tumors and intestinal metaplasia 
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(26). The use of NBI in the detection of these conditions was also accurate in other studies but 
due to study limitations reported results vary (27-30). 
IgG ELISA serology detects H. pylori antibodies and is relatively cheap and non-invasive but a 
positive test cannot distinguish between current and previously treated infection. Accuracy is 
variable but some commercial kits report accuracy of greater than 90% (31) with the benefit that 
results are not affected by proton pump inhibitor (PPI) treatment.
 Serum pepsinogen can be used to predict the extent of gastric atrophy. Pepsinogen I (PGI) and 
Pepsinogen II (PGII) are usually released from secretory cells found in the gastric mucosa. With 
the progression to atrophy this causes the loss of these secreting cells and reduces pepsinogen 
levels. PGI is more affected by this and thus the ratio is decreased further. Low pepsinogen I or 
pepsinogen I/II ratio less than 3 can signify moderate to severe corpus atrophy (13). For 
estimating gastric atrophy extent studies have described a huge variation in results with 
sensitivity and specificity from 9.4% to 92.3% and 9.9% to 100% respectively (13, 32-34). 
Serological markers of gastric atrophy are not routinely used in Western countries. 
No study has yet evaluated the utility of both magnified narrow band imaging and serology in the 
detection of premalignant gastric pathology. Patients referred for endoscopic investigation for 
iron deficiency anemia were selected for this study due to the association with both H. pylori and 
gastric atrophy (6, 35, 36). The Anagnostopoulos et al classification was adapted to use NBI-Z 
rather than WLE-Z in this study and termed the Nottingham classification. 
The primary aim of this pilot study was to assess the diagnostic accuracy of magnified NBI 
endoscopy and serology in diagnosing normal mucosa, H. pylori gastritis and gastric atrophy 
using the Nottingham classification. Secondary aims were to compare the diagnostic accuracies 
of two validated classification systems using both NBI-Z and WLE-Z and evaluate the inter-
observer agreement.
Material and Methods
Participants and clinical samples
150 adult patients (18-85yrs) attending Nottingham University Hospitals (NUH) NHS Trust for a 
diagnostic gastroscopy as part of their investigation into iron deficiency anemia were 
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prospectively recruited between August 2010 and December 2014. Derbyshire Research Ethical 
Committee (REC Ref: 10/H0401/33) approved the protocol and written informed consent was 
gained. Patients with low hemoglobin (<130g/l men & <120g/l women) and either a low MCV 
(<84fl) or low ferritin (<25mcg/l men & <13 mcg/l women) were recruited. Patients taking 
anticoagulants and proton pump inhibitors or individuals for whom biopsy sampling was 
contraindicated were not recruited. Patients who had an overt cause for iron deficiency anemia 
after both upper and lower GI investigations (e.g. malignancy (n=22), coeliac disease (n=9), poor 
quality digital images (n=2) or patients without biopsies (n=1)) were excluded. 116 patients were 
included in the final analysis. 
Laboratory Investigations
Fasting blood samples were collected and analyzed for full blood count, B12, folate, serum 
ferritin, transferrin saturation, transferrin, serum iron and iron binding capacity. Plasma was also 
stored at -80°C until processed for H. pylori IgG (Biohit), PG I (Biohit) and PG II (Biohit) with 
ELISA kits according to manufacturer’s instructions. 
Endoscopy procedures
Procedures were performed by expert endoscopists using pharyngeal local anaesthetic spray 
Xylocaine (AstraZeneca, Luton, UK) or conscious sedation (midazolam/pethidine) according to 
patient preference. A black soft rubber hood (MB46, MAJ-1990, Olympus) was attached to the 
endoscope tip to allow a fixed 2mm distance between gastric mucosa and gastroscope. All 
procedures were done with high definition and magnification Gastroscopes (GIF-FQ260Z; 
Olympus Optical, Tokyo, Japan) and Lucera Elite CV290 video processor. The video images 
were viewed on a high definition video monitor (OEV-191H, Olympus). During the procedure 
the mucosa was washed with a mixture containing 100ml of water mixed with 2ml of 
acetylcysteine (200mg/ml, Parvolex, Celltech, UK) and 0.5ml (40mg/ml) dimethicone (Infacol, 
Forrest Laboratories, UK). Detailed examination of the gastric mucosa was then carried out, in 
WLE and then NBI using both low magnification and magnified views. Still digital images were 
recorded in both WLE and NBI, with biopsies taken from the areas where the digital images 
were recorded. A minimum of 8 images were recorded for each patient. All still images were 
transferred to an external hard drive. 
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Post endoscopy image production
Images were stored as JPEG files (200-300 kilobytes, 1093x948 pixels, 32-bit color), edited, 
anonymized and given random numbers generated in Excel Office 2010 (Microsoft Corporation, 
Redmond, Washington, USA) before transfer into an evaluation set of folders according to area 
and classification system. Two principal endoscopists (Ragunath/Sami), experts in advanced 
endoscopy, agreed on the magnified appearance of each selected images of the gastric mucosa in 
WLE-Z and NBI-Z according to specific criteria. Both were blinded to clinical, histological and 
serological findings. Images were reviewed and graded according to mucosal morphology using 
the classifications described below. These scores were used to assess magnification endoscopy 
performance in terms of sensitivity, specificity, accuracy, positive and negative likelihood ratios. 
Image classification
Two validated classification systems were used for the gastric corpus: the Nottingham 
classification (Figure 1) (18)  and a modified Pimentel-Nunes et al classification (24) to include 
gastric atrophy (Db) termed the modified Porto classification (Table 1, Figure 2). 
Inter-observer variability study
Eight blinded endoscopists assessed the digital still images: four experienced, fully accredited 
endoscopists (experts) and four trainee endoscopists (non-experts). Prior to grading the images 
all endoscopists underwent a comprehensive, self-directed training package which covered all 
the gastric mucosa classifications. Each endoscopist viewed folders containing WLE-Z and NBI-
Z images of the corpus for both classifications. Approximately 464 anonymized randomized 
images were reviewed over an unrestricted length of time. Data on image classification from a 
drop down menu of pre-defined options and image quality according to a 10 point Visual 
Analogue Scale (VAS) (37) were recorded onto an Excel spreadsheet. 
Histopathology analysis
Two gastric antrum, two gastric corpus and four duodenal samples were fixed in formalin, then 
embedded in paraffin and cut into approximately 4µm sections. Sections were stained with 
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haematoxalin and eosin (H&E) to allow histological scores to be carried out according to the 
updated Sydney scoring system (38). All specimens were classified as none (0), mild (1), 
moderate (2) or severe (3) for the following histological features activity (polymorphonuclear 
cell infiltration), inflammation (mononuclear cell infiltration), atrophy (loss of specialized 
glands) and intestinal metaplasia (replacement gastric mucosa by metaplastic columnar 
absorptive cells and goblet cells with intestinal morphologic features). Toluidine blue staining 
was also carried out for H. pylori density grading. A single blinded expert GI histopathologist 
carried out the histological grading. One biopsy from the antrum was placed in urease medium 
for rapid urease detection, and another sample in iso-sensitest broth (Oxoid, Cambridge, 
UK)/10% glycerol for H. pylori isolation and culture. 
Statistical methods
Sensitivity, specificity, positive and negative likelihood ratios along with 95% confidence 
intervals (CI) for magnification endoscopy appearances and serological markers were compared 
with histology. A receiver operating characteristic (ROC) curve was used to assess the diagnostic 
accuracy. Chi-squared tests were used to compare the diagnostic accuracies. Kappa (k) statistics 
were calculated to determine inter-rater agreement among experts and non-experts.  
Interpretation of k values was as follows: <0= no agreement; 0–0.20= slight agreement; 0.21–
0.40= fair agreement; 0.41–0.60= moderate agreement; 0.61–0.80= substantial agreement; and 
0.81–1= almost perfect agreement (39). Differences in image quality were assessed using the 
Mann-Whitney U test. P values <0.05 were considered statistically significant. Stata version 14 
(Stata Corporation, College Station, Texas) was used for the statistical analysis.
Results
Patient characteristics are described in Table 2. 24% of patients had histological evidence of H. 
pylori infection, 35% had gastric atrophy and 14.7% had intestinal metaplasia.
Diagnostic accuracy of NBI-Z and serology 
NBI-Z diagnostic accuracy for determining normal corpus (Type I) was 0.87 (95% CI 0.82-
0.92), H. pylori gastritis (Type II/III) 0.65 (95% CI 0.55-0.75) and gastric atrophy (Type IV) 
0.88 (95% CI 0.81-0.94) respectively. 
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When NBI-Z was compared with serology, NBI-Z was superior for detecting gastric atrophy: 
NBI-Z Type IV 0.88 (95% CI 0.81-0.94) vs PG I/II ratio <3 0.74 (95% CI 0.62-0.85), p<0.0001 
and NBI-Z 0.88 (95% CI 0.81-0.94) vs PG<30μg/l 0.75 (95% CI 0.64-0.87), p<0.0001. Although 
H. pylori IgG had a numerically higher accuracy this did not achieve statistical significance, 
NBI-Z Type II/III 0.65 (95% CI 0.55-0.75) vs H. pylori IgG 0.82 (0.73-0.9), p=0.078. 
Diagnostic accuracy of NBI-Z and WLE-Z
Using the Nottingham classification, NBI-Z performed better than WLE-Z for detecting normal 
corpus and gastric atr phy. Normal corpus (Type I): NBI-Z 0.87 (95% CI 0.82-0.92) vs WLE-Z 
0.82 (95% CI 0.76-0.87), p<0.0001. Atrophy (Type IV): NBI-Z 0.88 (95% CI 0.81-0.94) vs 
WLE-Z 0.81 (95% CI 0.73-0.89), p<0.0001. However, WLE-Z performed better than NBI-Z for 
detecting H. pylori gastritis: NBI-Z 0.65 (CI 0.55-0.75) vs 0.69 (95% CI 0.6-0.79), p<0.0001. 
(Table 3). 
Diagnostic accuracy of the Modified Porto classification
NBI was more accurate than WLE for detecting normal mucosa, H. pylori gastritis and atrophy 
in the corpus. Normal corpus (Ab): NBI-Z 0.81 (95% CI 0.74-0.87) vs WLE-Z 0.79 (95% CI 
0.72-0.87), p<0.0001. H. pylori gastritis (Ab+): NBI-Z 0.77 (95% CI 0.67-0.87) vs WLE-Z 0.62 
(95% CI 0.51-0.74), p=0.01. Gastric atrophy (Db): NBI-Z 0.71 (95% CI 0.62-0.79) vs WLE-Z 
0.65 (95% CI 0.56-0.73), p<0.0001. For detecting intestinal metaplasia, there was no statistical 
difference in accuracy. Intestinal metaplasia (Bb): NBI-Z 0.66 (95% CI 0.53-0.79) vs WLE-Z 
0.59 (95% CI 0.45-0.73), p=0.28. (Table 4). 
Inter-observer agreement 
The mean kappa values for inter-observer agreement for NBI endoscopy images were higher 
among expert than non-experts endoscopists. For describing the corpus using the Nottingham 
classification the agreement was 0.63(95% CI 0.51-0.73) vs 0.5 (95% CI 0.39-0.62). When 
describing atrophy the agreement was 0.65 (95% CI 0.53-0.75) vs 0.47 (95% CI 0.2-0.68). Using 
the modified Porto classification when describing the corpus was 0.33 (95% CI 0.21-0.43) vs 0.2 
(95% CI 0.12-0.28). When describing intestinal metaplasia the agreement was 0.36 (95% CI 
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0.24-0.47) vs 0.21 (95% CI 0.1-0.34). Both expert and non-expert endoscopists rated the overall 
image quality VAS higher for NBI than WLE (7 vs 6 p<0.0001). 
Discussion
Standard WLE is limited in its ability to accurately diagnose gastric lesions, which has led to the 
development of a variety of techniques such as chromoendoscopy, NBI, flexible spectral imaging 
color enhancement (FICE), autofluorescence (AFI) and confocal laser endomicroscopy  (19) in 
addition to gold standard histology. NBI has been extensively studied for its use in detecting 
dysplasia in the esophagus, bronchus and in colonic polyps (19, 40-42).
We conducted this pilot study to assess the role of NBI and serology in predicting the 
histological diagnosis of gastric mucosa. We demonstrated good correlation with normal and 
gastric atrophy using magnification endoscopy. However, for detecting H. pylori gastritis our 
results were limited with an accuracy of 0.65 using the Nottingham classification. Endoscopic 
diagnosis of H. pylori infection requires a subjective assessment of vascular density of 
subepithelial capillary network (SECN). A more objective and accurate measurement may be 
needed to increase accuracy. Overall, NBI-Z performed better than both WLE-Z and serological 
markers for predicting disease. This was the first study to compare NBI-Z and serological 
markers with gastric pathology. 
The main factor influencing NBI appearance is light absorption by hemoglobin within blood 
vessels which in turn leads to variation in the vascular pattern of the gastric mucosa. The 
differences seen in gastric mucosa using NBI are a true reflection of the structural differences 
seen in vitro histologically.  This in turn allows NBI to predict histological diagnosis (43). The 
endoscopic appearance of gastric atrophy has been established since the 1970’s (44). The normal 
gastric body consists of a regular pattern of honeycomb type SECN and collecting venules but in 
H. pylori gastritis this is irregular and accompanied by surrounding edema (18, 45). 
Very few studies have investigated the endoscopic appearance of H. pylori gastritis, with nodular 
mucosal and gastric fold hypertrophy the most consistent features despite low sensitivities when 
compared to histology (46, 47). Thus the exact features that describe H. pylori gastritis are not 
entirely known which makes description and interpretation difficult. The findings using the 
Nottingham classification were lower than when initially described using WLE (18). Potential 
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reasons for this include the fact that the principal endoscopists scoring the images did not 
perform the procedures and, therefore, were blinded to potential clinical information that could 
influence decision making.  Although the modified Porto classification required more time to 
examine the images it also offered more details in terms of the presence of intestinal metaplasia 
and dysplasia. The specificity was high for normal mucosa, gastric atrophy and intestinal 
metaplasia. Potentially this could enable endoscopists to confidently avoid taking biopsies in the 
corpus.  The evidence for the use magnified endoscopy in detecting other disease shows the 
majority have good correlation with histology (18, 28, 48-50). Currently, the gold standard for 
the diagnosis of intestinal metaplasia and dysplasia remains histology despite promising results 
with NBI.  
When compared with serological markers, NBI-Z overall performed better. Previous studies 
have also shown that NBI is accurate in detecting premalignant lesions (29, 30, 51). The 
serological data presented in this study was similar to previous studies in terms of sensitivity and 
specificity (13, 31, 52, 53). H. pylori serology is commonly used in clinical practice in the UK 
but markers of atrophy are not. These results suggest the PG I/II ratio or PG I alone cannot 
replace endoscopy surveillance or detection of gastric atrophy. However, using this in clinical 
practice could reduce the need to obtain histology if serology is negative and NBI-Z does not 
suggest disease, therefore, reducing associated costs and time.
Inter-observer agreement was unsurprisingly higher among expert endoscopists when compared 
with non-experts. Endoscopy assessment is dependent on experience and training, so these 
techniques are likely to perform better in the hands of experts (54, 55). The training of western 
endoscopists is also likely to be different compared to Asian countries where the incidence of 
gastric cancer is higher. The observers VAS median scores were higher for NBI-Z than WLE-Z 
suggesting NBI provided more clarity to enable a diagnosis. 
Our results are more applicable to specialist centers that routinely use NBI endoscopy as it 
requires a certain skill level and so may not always be practical to use in routine clinical practice. 
In the same way, the captured images in this study were captured by endoscopists with advanced 
diagnostic imaging experience and this is unlikely to happen routinely. As shown by the lower 
agreement amongst non-experts, NBI requires training in mucosal pattern recognition. The main 
comparison was done with experts so if this was used in a real world setting the results may be 
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poorer. Also the time duration each endoscopist spent reviewing the still images for the inter-
observer study was not specified and unlike time constraints seen in clinical practice, possibly 
influencing the decision making process. In terms of training, this study did not measure inter-
observer agreement before and after the training session which would have given some insight 
into the learning required for NBI use in a routine clinical setting. 
Study strengths include the use of two endoscopy classification criteria to describe the magnified 
gastric mucosa in addition to serological markers in a large cohort of prospectively recruited 
patients. Post endoscopy image assessment controlled for clinician influence on pre-test 
probability. Bias was also reduced by blinding both the endoscopists and histopathologist to 
clinical data. Also the consistent use of the same gastroscope reduced image quality variability. 
Patients on proton pump inhibitors were also excluded to lower the number of false negatives in 
terms of H. pylori infection and to avoid missing early gastric neoplasia (56).  This work has 
provided further evidence to support routinely investigating the presence of gastric atrophy and 
H. pylori gastritis in iron deficiency anemia patients (31, 36). 
With regards to study limitations, by including only iron deficiency anemia patients this makes 
the study prone to selection bias and thus may not be representative at a population scale. 
However, as the annual incidence of gastric atrophy is low (0-10.9%) (57) we needed a larger 
cohort to enable estimates of sensitivity and specificity to be made to guide sample size 
calculations in future larger studies. Extent of disease also influenced the results. For example, 
atrophy serology tests only detect moderate to severe atrophy so endoscopy is more likely to 
perform better as these classifications only detect the presence of atrophy and not the degree. 
Inter-observer agreement for the modified Porto classification may also be lower due to the 
examiners been more familiar with the Nottingham classification at this specialist center. Finally, 
although the addition of atrophy to the modified Porto classification provided a more detailed 
description which more accurately resembled histology it also made the classification more 
complex and time consuming. The diagnosis of intestinal metaplasia is more reliable in terms of 
both histological grading and disease progression.
In conclusion, NBI-Z can detect changes in the GI mucosa which are usually dependent on 
histology. Although serology performs well, NBI endoscopy performs better in terms of disease 
detection with a high specificity and moderate to substantial observer agreement. A detailed 
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examination with NBI-Z could potentially help identify early precancerous lesions, which could 
enable patients to be promptly enrolled in appropriate endoscopic surveillance with improved 
disease outcomes.  Also NBI-Z use may allow stratification of the need for histology and thus 
minimize associated costs, time and sampling error. These study findings will help to design 
future trials to evaluate NBI techniques in the gastric mucosa.
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Figures
    
 
Figure 1 The Nottingham classification in gastric corpus
Type I (a) normal gastric body microvasculature = a honeycomb type subepithelial capillary network 
(SECN) and collecting venules in a regular arrangement. Type II (b) = honeycomb−type SECN with 
regular round pits, either with or without sulci, but with loss of collecting venules. Type III (c) = loss of 
the normal SECN and collecting venules, with enlarged white pits surrounded by erythema. Type IV (d) = 
loss of the normal SECN and round pits, with irregular arrangement of the collecting venules (18).
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A B
    
C D
Figure 2 Modified Porto gastric corpus classification
Normal corpus (Ab) in image (A), (B) H. pylori gastritis corpus (Ab+), (intestinal metaplasia in corpus 
with some light blue crest (Bb) in image (C) and atrophy in corpus (Db) in image (D). Magnification 
115X. 
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Tables
Table 1 Modified Porto classification
A* B* H. pylori+ C* D*
Mucosal 
pattern
Regular 
circular/oval
Regular
Ridge/tubulo-
villous with 
or without 
light blue 
crest
Regular
Irregular/ 
absent 
with or 
without 
white 
opaque 
substance
Absent
Vascular 
pattern 
(SECN)
Regular mucosa 
and SECN
Vascular pattern 
central in 
antrum/peripheral 
in corpus of gland
Regular
Regular/ 
variable 
vascular 
density
Irregular Absent
Expected 
outcome
Normal
Intestinal 
Metaplasia
H. pylori 
infection
Dysplasia
Atrophic 
gastritis
The letter (a) for antrum or (b) for corpus is added to the class type to signify the sites. For H. pylori 
positive pattern, the symbol (+) is added to end of the pattern class site. For e.g. H. pylori positive pattern 
in corpus would be classed as Ab+ (24).
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Table 2 Patient description and laboratory data
Numbers 116
Male: Female ratio 1:1.1
Age, median (range) years 67 (19-85)
% Pharyngeal local anesthetic: 
conscious sedation
38%:62%
Midazolam median dose (range) 3mg (1-5) 
Pethidine median dose (range) 25mg (25-100)
Hemoglobin males (130-
180g/L) median (range)
110g/L (85 -129)
Hemoglobin females (120-
165g/L) median (range)
101 g/L (42-118)
MCV (84-102fl) median (range) 83fl (56-111)
Ferritin (25-350µg/L) median 
(range)
12 µg/L (1-474)
Iron (9-31µmol/L) median 
(range)
11 µmol/L (1-83)
Histological diagnosis:
% H. pylori infection 24%
% Atrophy corpus 35%
% Intestinal metaplasia 14.7%
Presented as median with full range
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Table 3 Sensitivity, specificity and likelihood ratios with 95% CI of NBI-Z and WLE-Z for 
detecting H. pylori gastritis and gastric atrophy using the Nottingham classification and serology
Sensitivity (95% CI)
Specificity (95% 
CI)
Positive 
Likelihood 
ratio (95% CI)
Negative 
Likelihood 
ratio (95% CI)
NBI-Z Type I 75.6% (64.6-84.7) 98.6% (92.2-100) 54.0 (7.4-
366.8)
0.25 (0.17-
0.37)
WLE-Z Type I 66.2% (54.6-76.6) 96.8% (89-99.6) 20.7 (5.3-82.4) 0.35 (0.25-
0.48)
NBI-Z Type II/III 62.1% (42.3-79.3) 68.1% (58.8-76.4) 1.95 (1.32-
2.87)
0.56 (0.34-0.9)
WLE-Z Type II/III 74.1% (53.7-88.9) 64.9% (55-73.7) 2.11 (1.5-2.95) 0.40 (0.21-
0.77)
NBI-Z Type IV 75.6% (59.7-87.6) 100% (96.6-100) - -
WLE-Z Type IV 64.1% (47.2-78.8) 98% (93-99.8) 32.1 (8-130) 0.37 (0.24-
0.56)
H. pylori IgG 90% (68.3-98.8) 73.9% (61.9-83.7) 3.45 (2.26-
5.27)
0.14 (0.04-
0.51)
PG I/II ratio <3 73.7% (48.8-90.9) 73.8% (60.9-84.2) 2.81 (1.71-
4.63)
0.36 (0.17-
0.77)
PG I <30µg/l 52.6% (28.9-75.6) 98.4% (91.2-100) 32.11 (4.4-235) 0.48 (0.3-0.77)
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Table 4 Sensitivity, specificity and likelihood ratios with 95% confidence intervals of NBI-Z and 
WLE-Z using the modified Porto classification in the corpus
Sensitivity (95% CI)
Specificity (95% 
CI)
Positive 
Likelihood 
ratio (95% CI)
Negative 
Likelihood 
ratio (95% CI)
NBI-Z Ab 70.5% (59.8-79.7) 90.9% (78.3-97.5) 7.75 (3-19.9) 0.32 (0.23-
0.45)
WLE-Z Ab 77.8% (66.4-86.7) 81% (65.9-91.4) 4.09 (2.2-7.7) 0.27 (0.17-
0.43)
NBI-Z Ab+ 75% (53-90.2) 78.7% (69.8-86) 3.52 (2.3-5.4) 0.32 (0.16-
0.64)
WLE-Z Ab+ 43.5% (23.2-65.5) 81.3% (71.8-88.7) 2.33 (1.24-4.4) 0.69 (0.48-
1.01)
NBI-Z Bb 35.7% (12.8-64.9) 95.8% (90.4-98.6) 8.43 (2.78-
25.5)
0.67 (0.45-
0.99)
WLE-Z Bb 27.3% (6-61) 90.1% (82.5-95.1) 2.75 (0.89-
8.53)
0.81 (0.56-
1.17)
NBI-Z Db 70% (52-81) 99% (94.5-100) 70.0 (10.74-
307)
0.30 (0.23-
0.78)
WLE-Z Db 61% (45-76) 100% (95.7-100) - 0.39 (0.27-
0.50)
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Type I (a) normal gastric body microvasculature = a honeycomb type subepithelial capillary network (SECN) 
and collecting venules in a regular arrangement. 
60x52mm (220 x 220 DPI) 
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Type II (b) = honeycomb−type SECN with regular round pits, either with or without sulci, but with loss of 
collecting venules. 
93x83mm (96 x 96 DPI) 
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Type III (c) = loss of the normal SECN and collecting venules, with enlarged white pits surrounded by 
erythema. 
59x51mm (220 x 220 DPI) 
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Type IV (d) = loss of the normal SECN and round pits, with irregular arrangement of the collecting venules 
(18). 
57x52mm (220 x 220 DPI) 
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Normal corpus (Ab) in image (A) 
165x146mm (72 x 72 DPI) 
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(B) H. pylori gastritis corpus (Ab+) 
61x51mm (220 x 220 DPI) 
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Intestinal metaplasia in corpus with some light blue crest (Bb) in image (C) 
59x51mm (220 x 220 DPI) 
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Atrophy in corpus (Db) in image (D). Magnification 115X. 
61x51mm (220 x 220 DPI) 
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